China’s in-vitro diagnostic market still small, but growing at 15 – 20 % annually

According to Bio Valley Founder ZHANG Bao, China’s market for these products is 20 billion yuan , of which 13 billion yuan are reagents. Per capita consumption of diagnostic products is only about $ 2, as compared to $ 25-30 in developed countries. Roche , Siemens, Abbott, Beckman Coulter , BD and Sysmex account for 60% of domestic IVD market share. Mindray and Kehua are the Chinese leaders. With a tendency to improved quality of life, the size of the market is expected to exceed 30 billion yuan by 2015.

China Bio news release, May 5, 2014

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny